Oruka Therapeutics, Inc. ORKA
- ORKA-002 — Psoriasis Phase 2
IL-17A/F (2 companies · 2 programs)
Companies with an active program directed at IL-17A/F.
Spyre Therapeutics, Inc. SYRE
- SPY772 — Hidradenitis Suppurativa Preclinical
Companies with an active program directed at IL-17A/F.